IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Mr. Ari Bousbib 2016 'den beri şirketle birlikte olan IQVIA Holdings Inc 'in Chairman of the Board 'ıdır.
IQV hissesinin fiyat performansı nasıl?
IQV 'in mevcut fiyatı $176.42 'dir, son işlem günde 0% disminuido etti.
IQVIA Holdings Inc için ana iş temaları veya sektörler nelerdir?
IQVIA Holdings Inc Life Sciences Tools & Services endüstrisine ait ve sektör Health Care 'dir
IQVIA Holdings Inc 'in piyasa değerlemesi nedir?
IQVIA Holdings Inc 'in mevcut piyasa değerlemesi $29.6B 'dir
IQVIA Holdings Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 25 analist IQVIA Holdings Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 10 güçlü al, 14 al, 5 tut, 0 sat ve 10 güçlü sat içermektedir